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Purpose: To describe phenotypic characteristics of two pedigrees manifesting early onset crystalline cataract with
mutations in the γD-crystallin gene (CRYGD).
Methods: A detailed medical history was obtained from two Caucasian pedigrees manifesting autosomal dominant
congenital cataracts. Genomic DNA was extracted from saliva (DNA Genotek). Single Nucleotide Polymorphism (SNP)
based genome analysis of the larger pedigree revealed linkage to an 8.2 MB region on chromosome 2q33-q35 which
encompassed the crystallin-gamma gene cluster (CRYG). Exons and flanking introns of CRYGA, CRYGB, CRYGC and
CRYGD were amplified and sequenced to identify disease-causing mutations.
Results: A morphologically unique cataract with extensive refractile “crystals” scattered throughout the nucleus and
perinuclear cortex was found in the probands from both pedigrees. A heterozygous C→A mutation was identified at
position 109 of the coding sequence (R36S of the processed protein) in exon 2 of CRYGD and this missense mutation was
found to cosegregate with the disease in the larger family; this mutation was then identified in affected individuals of
pedigree 2 as well.
Conclusions: The heterozygous 109C→A CRYGD missense mutation is associated with a distinct crystalline cataract in
two US Caucasian pedigrees. This confirms crystalline cataract formation with this mutation, as previously reported in
sporadic childhood case from the Czech Republic and in members of a Chinese family.
Congenital and developmental cataracts are an important
cause of visual impairment in children [1]. Most bilateral
congenital cataracts, whether familial or sporadic, consist of
nuclear opacities. Many of these nuclear opacities are dense
at birth and require early surgery, while others are progressive
[2]. Several phenotypically unique morphologic variants have
been previously described, and are easily recognizable by the
examining ophthalmologist. Examples include the cerulean
cataract [3], the pulverulant and/or zonular type congenital
cataracts (Coppock-type) [4], the aculeiform cataract [5,6],
and the coralliform cataract [7-9]. Most of these cataracts
consist of whitish appearing opacities, and lens changes that
appear “crystalline” are uncommon.
Studies  of  families  with  heritable  cataract  commonly
show mutations in genes for lens crystallins. Crystallins (α-,
β-, γ-) are the major water soluble proteins expressed in the
lens,  and  play  a  critical  role  in  maintaining  lens  clarity.
Mutations in the γ-crystallin gene (most commonly CRYGC
and CRYGD) are responsible for multiple types of autosomal
dominant  cataracts,  including  pulverulent,  aceuliform,
cerulean, and lamellar cataracts [2]. Correlations have been
noted between specific missense mutations in the γ-crystallin
genes and specific cataract phenotypes.
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Previously, a 109C→A missense mutation in CRYGD
was identified in a 5-year-old Czech boy [10] with a unique
crystalline cataract, and in a Chinese family with congenital
“golden”  crystalline  lens  changes  [11].  In  this  report  we
describe a crystalline cataract with the recognizable feature of
clear refractile crystal formation in two families, and find that
both harbor the CRYGD 109C→A missense mutation.
METHODS
Members of two families manifesting autosomal dominant
congenital  cataracts  participated  in  this  genetic  study,
approved by the Institutional Review Board of Children’s
Hospital, Boston, MA. Signed informed consent was obtained
from all participants or their guardians, conforming to the
Declaration  of  Helsinki.  The  probands  presented  with
congenital cataracts and underwent detailed ophthalmologic
evaluations.  Clinical  characteristics  of  the  probands  were
documented, and family ocular history was obtained. Medical
records with regard to cataract description in family members
were  not  available,  and  all  affected  family  members  had
already undergone bilateral cataract removal at the time of this
study.
For each study participant, genomic DNA was extracted
from saliva and saliva sponge kits using the purifier solution
(DNA Genotek Inc., Kanata, Ontario, Canada). Genome-wide
Single  Nucleotide  Polymorphism  (SNP)  data  for  linkage
analysis was obtained from participating members of pedigree
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33331 using the Affymetrix’s GeneChip Human Mapping 10K 2.0
SNP array (Affymetrix, Santa Clara, CA). The resulting CHP
files were imported into Progeny Software, cleaned, and then
exported for linkage analysis. Fast multipoint linkage analysis
was performed using Allegro version 2 assuming a dominant
mode of inheritance with full penetrance and a disease gene
frequency  of  0.0001  [12].  Based  on  the  linkage  results
presented below, the four genes in the crystalline-gamma gene
cluster  (CRYGA,  CRYGB,  CRYGC,  and  CRYGD)  were
positional gene candidates. Primer sets comprising exonic and
flanking intronic sequences of these genes were designed
based on the NCBI36/hg18 human reference assembly. DNA
from  participants  of  both  pedigrees  were  amplified  using
HotStar Taq DNA polymerase (Qiagen, Hilden, Germany)
and directly sequenced by Sanger sequencing (ABI Sequence
Analyzer; Applied Biosystems, Foster City, CA). Sequencher
(Gene Codes Corporation, Ann Arbor, MI) was then used to
analyze the sequence data.
RESULTS
Clinical description of probands: A female infant member of
Pedigree 1 was first examined in the Ophthalmology clinic at
5 weeks of age. Bilateral cataracts had been suspected on
prenatal ultrasound, and her pediatrician confirmed a poor red
reflex after birth. She had also been diagnosed prenatally with
a complex congenital heart defect with transposition of the
great arteries, for which she remained hospitalized after birth
and  underwent  repair  at  one  week  of  age.  There  was  an
extensive  family  ocular  history  of  congenital  cataract,
however no other family member had congenital heart disease
or other congenital systemic abnormalities.
Complete ophthalmoscopic exam was performed. She
was  noted  to  fix  on  lights,  without  following;  pupillary
reactions were normal. Intraocular pressures were 8 mmHg
by Perkins tonometry. Even after dilation, a poor red reflex
was seen, and retinoscopy could not be performed. The patient
underwent uneventful sequential cataract extraction at 8 and
9 weeks of age in the right and left eye, respectively. She was
left  aphakic  and  fitted  with  contact  lens  correction.  She
eventually underwent intraocular lens implantation and her
Snellen visual acuity at age 10 years was 20/50 in each eye.
A  male  infant  member  of  Pedigree  2  was  seen  for
ophthalmologic  evaluation  at  1  week  of  age,  after  his
pediatrician detected an abnormal red reflex in the newborn
nursery. Tiny “specks” were seen in the nucleus of the lens,
with clear peripheral and intervening lens, allowing a clear
view  to  the  fundus  using  direct  ophthalmoscopy  and
retinoscopy. He was re-examined every 3 months to monitor
the density of the cataract and its impact on visual acuity. By
4 years of age, the density of the specks, which now appeared
crystal-like, increased, with a corresponding decline in visual
acuity to 20/125 in the right eye and 20/200 in the left eye. He
underwent cataract extraction in both eyes with intraocular
lens implantation. The final corrected Snellen visual acuity
was 20/20 for each eye.
Morphology of cataracts: The cataracts of both probands were
morphologically  unique  from  more  common  types  of
congenital  nuclear  cataracts,  with  extensive  refractile
“crystals” scattered throughout the nucleus and perinuclear
cortex. Intervening areas of clear lens could be seen. Under
the operating microscope these crystals were confirmed to be
essentially transparent, but were densely packed and refractile
(Figure 1). No whitish or gray opacities in the crystals were
seen. As evidenced by the patient from pedigree 2, progression
of crystal formation was noted both by a decline in vision and
by inability to perform retinoscopy or adequately view the
fundus.
Description  of  pedigrees:  Both  pedigrees  segregate  early
onset cataract in an autosomal dominant fashion. Pedigree 1
is a five-generation Caucasian (Northern European) pedigree
from which 23 individuals were enrolled, 12 of whom were
affected (Figure 2A). The family history was reviewed and
records obtained for this child’s mother, who had cataract
removal  at  2  years  of  age  but  was  left  with  deprivation
amblyopia  due  to  late  intervention.  All  affected  family
members were either aphakic or pseudophakic, though timing
and  technique  of  cataract  removal  varied  by  historical
standard  of  care.  Pedigree  2  is  a  2-generation  Caucasian
Iranian pedigree from which 3 individuals were enrolled, 2 of
whom  were  affected  (Figure  2B).  All  affected  family
members  also  had  bilateral  involvement,  with  cataract
Figure  1.  Cataract  morphology.  A:
proband of Pedigree 1 and B: proband
of  Pedigree  2  as  viewed  under  an
operating microscope.
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care.
Genetic analysis: Genetic analysis of pedigree 1 revealed
linkage to an 8.2 MB region on chromosome 2q33-q35 with
a maximal Log of Odds (LOD) score of 4.15. The linked
region  encompassed  the  crystallin-gamma  gene  cluster
(CRYG).
The four genes in CRYG cluster were sequenced. No
mutations were identified in CRYGA, CRYGB, or CRYGC. A
heterozygous C→A transversion was identified at position
109 in exon 2 of CRYGD (109C→A) in each of the probands,
and  co-segregated  with  the  disease  phenotype  in  both
pedigrees (Figure 3). This nucleotide substitution is predicted
to result in the substitution of the wild type positively charged
and  bulky  arginine  residue  for  a  polar  uncharged  serine
residue (R36S of the processed, NH2-terminal methionine-
lacking CRYGD protein) [10]. The arginine residue is highly
conserved. Kmoch et al. [10] and Gu et al. [11] previously
reported absence of the mutation in 200 control alleles and it
is not reported in dbSNP build 132.
DISCUSSION
CRYGC and CRYGD encode abundant lens γ-crystallins in
humans,  and  almost  90%  of  γ-crystallins  synthesized  in
human  lens  are  the  products  of  these  two  genes  [13,14].
CRYGD γ-crystallins are expressed at high concentrations in
the fiber cells of the human embryonic lens and these cells
subsequently  form  the  lens  nucleus  fibers.  Mutations  in
Figure 2. Schematic representation of pedigrees. For each pedigree, squares and circles denote males and females, respectively. Filled squares
and circles denote that the individual had cataracts. Diagonal line denotes deceased family member. The proband for each pedigree is indicated
by an arrowhead. A: Pedigree 1. For each participant, ‘+’ indicates presence of the CRYGD 109 C→A mutation (R36S) and ‘-‘ indicates a
wildtype allele. Note that the heterozygous CRYGD mutation segregates with the dominant crystalline cataract phenotype. B: Pedigree 2. The
affected mother and son harbor a heterozgous CRYGD 109 C→A mutation, while the unaffected father has two wildtype alleles.
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3335CRYGC and CRYGD have been identified to cause autosomal
dominant congenital cataract as a result of altered stability,
association  and/or  solubility  of  γ-crystallins  [15-22].  We
report 2 Caucasian families with a phenotypically distinct
early onset crystalline cataract associated with a heterozygous
109C→A missense mutation in CRYGD that is predicted to
result in a R36S amino acid substitution. The density of the
crystals, along with the refractile diffraction and prismatic
effects, was the cause of visual morbidity, rather than the
opaque whitish changes described in other types of congenital
crystalline cataracts, including the aculeiform and coralliform
crystalline cataracts.
There  have  been  two  previous  reports  of  congenital
cataracts in patients harboring the identical 109C→A point
mutation in CRYGD. The cataract phenotype in both of the
current probands was most similar to that in the first report of
a sporadic case described by Kmoch et al. [10]. This 5-year-
old  boy  had  bilateral  cataracts  with  symmetric  crystal
deposition and greyish opacities in both lenses. In both lenses
numerous  birefringent  pleiochromic,  macroscopically
prismatic crystals were seen, with a higher density in the fetal
and infantile nucleus and a lower density in the lens cortex.
Using protein crystallography, the authors demonstrated that
the R36S amino acid substitution alters molecular surface
charges and decreases protein solubility, resulting in crystal
formation. In the second report, Gu et al. [11] described a
pedigree that co-segregated the R36S CRYGD amino acid
substitution  with  slowly  progressing  bilateral  nuclear
cataracts consisting of a “central pulverulent opacity affecting
the  embryonal,  fetal,  and  infantile  nucleus  of  the  lens,
characterized by golden crystal punctuate, with metal-like
refractivity in the opaque nucleus.”
The difference in phenotype among pedigrees harboring
the  identical  109C→A  CRYGD  heterozygous  missense
mutation  (prismatic  effects  versus  metal  like  or  grayish
opacities) may be related to the effect of aging. It is interesting
to note that the probands in our study presented at a young age
when  the  lens  is  expected  to  be  clear,  and  hence,  only
prismatic and refractile effects were seen. It is possible that
the nucleus becomes more brunescent and other opacities may
develop with the effect of aging, and may contribute to the
“metal like” color or gray opacities as observed in the Chinese
family. Alternatively, it is possible that the R36S phenotype
is  modified  by  genetics  or  the  environment,  as  has  been
demonstrated for the R58H CRYGD substitution that also
results in a crystalline cataract. This substitution typically
causes the aculeiform crystalline cataract, a phenotypically
recognizable cataract characterized by white fiberglass-like or
needle-like crystals projecting in different directions [23]. In
one four-generation Mexican family segregating the R58H
CRYGD substitution, however, all mutation-positive family
members  had  congenital  aculeiform  cataracts  with  the
exception of one, who had a “coral-like” cataract that is a
phenotype  classically  distinguished  from  the  aculeiform
cataract [24]. Pande et al. [25] has demonstrated that both the
R36S  and  R58S  CRYGD  mutant  proteins  are  much  less
Figure  3.  Chromatogram  showing
sequence analysis of CRYGD at exon 2.
Chromatograph of an affected (V:1) and
unaffected  (V:2)  individual  from
Pedigree 1 and unaffected (III:1) and
unaffected  (II:1)  individual  from
Pedigree  2  in  in  which  a  C→A
transversion at position 109 resulted in
the R36S mutation.
Molecular Vision 2011; 17:3333-3338 <http://www.molvis.org/molvis/v17/a359> © 2011 Molecular Vision
3336soluble and more prone to crystallization than the wild type
human  gamma-B-crystallin  protein,  but  the
pathophysiological cause of the phenotypic variability is not
yet understood.
Variable onset or rate of progression of cataract is also
known to occur, as reported by Stephan et al. [18] in a 3-
generation family with punctate progressive juvenile cataract
associated with R14C mutation in CRYGD. In this family, the
lenses were clear at birth, but developed focal greyish-white
punctate opacities in the nucleus and surrounding deep cortex
with  time  that  required  lens  extraction.  Protein  modeling
suggested that the effect of this mutation was a subtle one,
affecting  the  surface  properties  of  the  crystallin  molecule
rather than its tertiary structure, consistent with the fact that
the lenses were normal at birth. Nandrot et al. [26] found a
mutation in CRYGD (P23T) of chromosome 2q33–35 in a 4-
generation  Moroccan  family  with  autosomal  dominant
cerulean cataract. This mutation alters the protein folding or
decreases the thermodynamic stability or solubility of the
protein. A different mutation in the same codon (P23S) was
found  by  Plotnikova  et  al.  [27]  to  be  the  basis  of  the
polymorphic congenital cataract reported by Rogaev et al.
[28]. McManus et al. [29] found that CRYGD proteins with
cataract-associated mutations of pro23 became less soluble as
temperature  increased,  in  dramatic  contrast  to  the  native
protein.
Crystalline lens opacities have also been described as a
phenotypic variant of the progressive childhood cataract seen
in  the  Hyperferritinemia  Cataract  Syndrome,  but  in  this
condition the crystals appear as square solid opacities, with
the clinical appearance usually described as pulverulent or
sunflower  like  [30-33].  These  cataracts  are  caused  by
mutations in the ferritin light chain (FTL) on chromosome 19.
Individuals with this syndrome have hyperferritinemia, and
elevated ferritin levels in extracted lenses have also been noted
[34].
In conclusion, we confirm that an autosomal dominant
crystalline  cataract,  recognizable  by  distinct  phenotypic
features,  is  associated  with  an  R36S  CRYGD  crystallin
mutation in 2 pedigrees described in this article. This cataract
is congenital and progressive, so that surgery was performed
eventually  for  all  affected  family  members,  with  both
probands operated in early childhood.
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